Essais liés8clinical trials
VilleBelgradelocalisation
PaysSerbialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05066217

Ouvrir le site du centre

Essais cliniques associés

8
MoléculeIndication / populationPhaseNCTTitreStatut
Soticlestat Épilepsie Phase 3 NCT04940624 A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome COMPLETED
Soticlestat Épilepsie Phase 3 NCT05163314 A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome TERMINATED
Soticlestat Épilepsie Phase 3 NCT04938427 A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome COMPLETED
Ocrelizumab SEP Phase 3 NCT05123703 Operetta 2 — A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) ACTIVE_NOT_RECRUITING
Clemizole HCl Épilepsie Phase 3 NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome RECRUITING
LP352 Épilepsie Phase 3 NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) RECRUITING
LP352 Épilepsie Phase 3 NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) ACTIVE_NOT_RECRUITING
LP352 Épilepsie Phase 3 NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) ENROLLING_BY_INVITATION